1 August 2025
Pro Bono Team Advises Global RDH12 Alliance and Eyes on the Future in Collaboration with Opus Genetics to Advance Gene Therapy for Inherited Childhood Blindness
Advising firms
Deal team
7 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| David McIntosh | Ropes & Gray | Partner | life sciences licensing | Not stated |
| David Dowling | Ropes & Gray | Counsel | emerging companies & venture capital | Not stated |
| Parker Elliot | Ropes & Gray | Associate | life sciences licensing | Not stated |
| Ryan Kramer | Ropes & Gray | Associate | life sciences licensing | Not stated |
| Mo Greason | Ropes & Gray | Associate | life sciences licensing | Not stated |
| Daisy Bray | Ropes & Gray | Associate | life sciences regulatory & compliance | Not stated |
| Robyn Bond | Ropes & Gray | Associate | data, privacy & cybersecurity | Not stated |
4 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 1.60m ($1.6 million)
- What the figure measures
- Total transaction value
- Client
- Not stated
- Counterparties
- Opus Genetics, Inc. (Other)
Global RDH12 Alliance (Other)
Eyes on the Future (Other)